{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:28:42Z","timestamp":1790184522252,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.cyto.2011.04.022","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T06:44:58Z","timestamp":1306219498000},"page":"288-293","source":"Crossref","is-referenced-by-count":62,"title":["Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10"],"prefix":"10.1016","volume":"55","author":[{"given":"Alessandro","family":"Antonelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Martina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Frascerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Franzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Miccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Paolicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poupak","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2011.04.022_b0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.182.5.1301","article-title":"Human Mig chemokine: biochemical and functional characterization","volume":"182","author":"Liao","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2011.04.022_b0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI9775","article-title":"Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity","volume":"107","author":"Romagnani","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2011.04.022_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s","volume":"187","author":"Bonecchi","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2011.04.022_b0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.173.2.417","article-title":"5\u2032 regulatory region of a novel cytokine gene mediates selective activation by interferon gamma","volume":"173","author":"Wright","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2011.04.022_b0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","article-title":"CXCR3, inflammation, and autoimmune diseases","volume":"1173","author":"Lacotte","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cyto.2011.04.022_b0030","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1161\/hc4601.098010","article-title":"Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection","volume":"104","author":"Melter","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2011.04.022_b0035","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1084\/jem.192.10.1515","article-title":"Requirement of the chemokine receptor CXCR3 for acute allograft rejection","volume":"192","author":"Hancock","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2011.04.022_b0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.193.8.975","article-title":"Donor-derived IP-10 initiates development of acute allograft rejection","volume":"193","author":"Hancock","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2011.04.022_b0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2990.2000.026002133.x","article-title":"Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions","volume":"26","author":"Simpson","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.cyto.2011.04.022_b0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO;2-Z","article-title":"The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions","volume":"184","author":"Goebeler","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.cyto.2011.04.022_b0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/clim.2000.4957","article-title":"CXCR3 and CCR5 ligands in rheumatoid arthritis synovium","volume":"98","author":"Patel","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cyto.2011.04.022_b0060","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.4049\/jimmunol.163.9.4878","article-title":"T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig","volume":"163","author":"Koga","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.022_b0065","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1210\/jc.2004-0977","article-title":"High levels of circulating CXCL10 are associated with chronic autoimmune thyroiditis and hypothyroidism","volume":"89","author":"Antonelli","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cyto.2011.04.022_b0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/eje.1.01847","article-title":"Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis","volume":"152","author":"Antonelli","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cyto.2011.04.022_b0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yexmp.2004.08.004","article-title":"Early chemokine expression induced by interferon-gamma in a murine model of Hashimoto\u2019s thyroiditis","volume":"77","author":"Kimura","year":"2004","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.cyto.2011.04.022_b0080","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1210\/jc.2008-2450","article-title":"Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves\u2019 disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"94","author":"Antonelli","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cyto.2011.04.022_b0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cyto.2010.01.009","article-title":"Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"50","author":"Antonelli","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2011.04.022_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ncpendmet1027","article-title":"Endocrine manifestations of hepatitis C virus infection","volume":"5","author":"Antonelli","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.cyto.2011.04.022_b0095","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-2008-1073151","article-title":"Circulating chemokines in patients with autoimmune thyroid diseases","volume":"40","author":"Domberg","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cyto.2011.04.022_b0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cyto.2007.06.006","article-title":"Dynamic alteration of soluble serum biomarkers in healthy aging","volume":"39","author":"Shurin","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2011.04.022_b0105","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.4049\/jimmunol.168.5.2470","article-title":"A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transform nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis","volume":"168","author":"Wang","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.022_b0110","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1073\/pnas.020522597","article-title":"Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid","volume":"97","author":"Caturegli","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2011.04.022_b0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri750","article-title":"Autoimmune thyroid disease: new models of cell death in autoimmunity","volume":"2","author":"Stassi","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2011.04.022_b0120","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.5401","article-title":"Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves\u2019 disease, and modulation by methimazole therapy and thyroidectomy","volume":"93","author":"Antonelli","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.cyto.2011.04.022_b0125","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1210\/jc.2006-1571","article-title":"Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves\u2019 disease or toxic nodular goiter","volume":"92","author":"Antonelli","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cyto.2011.04.022_b0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0070-2153(05)68006-4","article-title":"Chemokine receptor CXCR3: an unexpected enigma","volume":"68","author":"Liu","year":"2005","journal-title":"Curr Top Dev Biol"},{"key":"10.1016\/j.cyto.2011.04.022_b0135","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood.V98.13.3554","article-title":"Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties","volume":"98","author":"Proost","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2011.04.022_b0140","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.164.12.6503","article-title":"Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells","volume":"164","author":"Marx","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.022_b0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1749-6632.2001.tb03952.x","article-title":"Lysophosphatidylcholine inhibits T cell-specific CXC chemokines IP-10, MIG, and I-TAC expression induced by IFN-gamma in human endothelial cells","volume":"947","author":"Sheikh","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cyto.2011.04.022_b0150","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.165.3.1548","article-title":"CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma","volume":"165","author":"Jinquan","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.022_b0155","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1096\/fj.99-0963com","article-title":"Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells","volume":"14","author":"Salcedo","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.cyto.2011.04.022_b0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI7335","article-title":"The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis","volume":"104","author":"Trentin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2011.04.022_b0165","doi-asserted-by":"crossref","first-page":"45098","DOI":"10.1074\/jbc.M106912200","article-title":"Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells","volume":"276","author":"Robledo","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2011.04.022_b0170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V96.4.1230","volume":"96","author":"Jinquan","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2011.04.022_b0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(00)00285-X","article-title":"Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1\/2 activation and role in Alzheimer\u2019s disease","volume":"108","author":"Xia","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2011.04.022_b0180","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1074\/jbc.M005652200","article-title":"The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3","volume":"276","author":"Loetscher","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2011.04.022_b0185","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1167\/iovs.04-1010","article-title":"Synthesis of alpha-chemokines IP-10, I-TAC, and MIG are differentially regulated in human corneal keratocytes","volume":"46","author":"McInnis","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cyto.2011.04.022_b0190","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4049\/jimmunol.169.3.1556","volume":"169","author":"Zhao","year":"2002","journal-title":"J Immunol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T20:04:52Z","timestamp":1686081892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466611001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1043466611001463"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2011.04.022","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}